Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNASEL | Q05823 | 7/20 | 0.56 |
| ▸ | P2RY2 | P41231 | 4/20 | 0.53 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.50 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.50 |
| ▸ | P2RY1 | P47900 | 4/20 | 0.46 |
| ▸ | SRC | P12931 | 1/20 | 0.46 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.46 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.46 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.46 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | DTYMK | P23919 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26201729 | 0.98 | RNASEL (0.58) | RNASELP2RY2P2RY4P2RY6P2RY1 | |
| SCHEMBL26206302 | 0.96 | RNASEL (0.58) | RNASELP2RY2P2RY4P2RY6P2RY1 | |
| SCHEMBL26202441 | 0.96 | RNASEL (0.61) | RNASELP2RY2P2RY4P2RY6 | |
| SCHEMBL26214226 | 0.95 | RNASEL (0.56) | RNASELP2RY2P2RY4P2RY6P2RY1 | |
| SCHEMBL26202067 | 0.95 | RNASEL (0.56) | RNASELP2RY2P2RY4P2RY6P2RY1 | |
| SCHEMBL26214231 | 0.95 | RNASEL (0.56) | RNASELP2RY2P2RY4P2RY6P2RY1 | |
| SCHEMBL26214217 | 0.95 | RNASEL (0.55) | RNASELP2RY2P2RY4P2RY6P2RY1 | |
| SCHEMBL26579101 | 0.94 | RNASEL (0.57) | RNASELP2RY2P2RY4P2RY6P2RY1 | |
| SCHEMBL26213497 | 0.94 | RNASEL (0.63) | RNASELP2RY2P2RY4P2RY6P2RY1 | |
| SCHEMBL26212708 | 0.94 | RNASEL (0.57) | RNASELP2RY2P2RY4P2RY6P2RY1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023159930-A1 | COMPOUND FOR RNA CAPPING AND APPLICATION OF COMPOUND | 广州市恒诺康医药科技有限公司 | 2023-08-31 | — | — | WO | disclosed |